Outcome selection for tissue-agnostic drug trials for immune mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

Olalekan Lee Aiyegbusi*, Lavinia Ferrante di Ruffano, Ameeta Retzer, Philip Newsome, Christopher Buckley, Melanie Calvert

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

54 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Outcome selection for tissue-agnostic drug trials for immune mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance'. Together they form a unique fingerprint.

Medicine & Life Sciences